Punt CJA - Search Results

1

Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.

Pander J, Wessels JAM, Gelderblom H, van der Straaten T, Punt CJA, Guchelaar HJ. Pander J, et al. Among authors: punt cja. Ann Oncol. 2011 May;22(5):1147-1153. doi: 10.1093/annonc/mdq572. Epub 2010 Nov 3. Ann Oncol. 2011. PMID: 21048041 Free article. Clinical Trial.

2

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study.

Punt CJ, de Mulder PH, Burghouts JT, Wagener DJ. Punt CJ, et al. Cancer Chemother Pharmacol. 1992;29(4):326-8. doi: 10.1007/BF00685954. Cancer Chemother Pharmacol. 1992. PMID: 1537082 Clinical Trial.

3

Current status and future directions in the perioperative treatment of pancreatic cancer.

Wagener DJ, Punt CJ, Wilke H. Wagener DJ, et al. Ann Oncol. 1994;5 Suppl 3:87-90. doi: 10.1093/annonc/5.suppl_3.s87. Ann Oncol. 1994. PMID: 8204535 Review.

4

New drugs in the treatment of colorectal carcinoma.

Punt CJ. Punt CJ. Cancer. 1998 Aug 15;83(4):679-89. doi: 10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f. Cancer. 1998. PMID: 9708931 Review.

5

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG).

Punt CJ, Fumoleau P, van de Walle B, Faber MN, Ravic M, Campone M. Punt CJ, et al. Ann Oncol. 2001 Sep;12(9):1289-93. doi: 10.1023/a:1012287111922. Ann Oncol. 2001. PMID: 11697842 Free article. Clinical Trial.

6

Adjuvant interferon-alpha for melanoma revisited: news from old and new studies.

Punt CJ, Eggermont AM. Punt CJ, et al. Ann Oncol. 2001 Dec;12(12):1663-6. doi: 10.1023/a:1013592219007. Ann Oncol. 2001. PMID: 11843241 Free article. Review.

7

Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study.

Punt CJ, Keizer HJ, Douma J, Skovsgaard T, Schüller J, Muller EW, Ten Napel CH, Croles JJ, Lochs H, Zhang J, Hammershaimb L. Punt CJ, et al. Ann Oncol. 2002 Jan;13(1):81-6. doi: 10.1093/annonc/mdf045. Ann Oncol. 2002. PMID: 11865814 Free article. Clinical Trial.

8

Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer.

Punt CJ, Blanke CD, Zhang J, Hammershaimb L. Punt CJ, et al. Ann Oncol. 2002 Jan;13(1):92-4. doi: 10.1093/annonc/mdf044. Ann Oncol. 2002. PMID: 11865815 Free article. Clinical Trial.

9

Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors.

Punt CJ, Boni J, Bruntsch U, Peters M, Thielert C. Punt CJ, et al. Ann Oncol. 2003 Jun;14(6):931-7. doi: 10.1093/annonc/mdg248. Ann Oncol. 2003. PMID: 12796032 Free article. Clinical Trial.

10

Systemic treatment of advanced colorectal carcinoma.

van Laarhoven HW, Punt CJ. van Laarhoven HW, et al. Eur J Gastroenterol Hepatol. 2004 Mar;16(3):283-9. doi: 10.1097/00042737-200403000-00006. Eur J Gastroenterol Hepatol. 2004. PMID: 15195891 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters